News

New Multiple Sclerosis Lesions Accrue Seasonally


 

What is of great concern, however, is that MRI variables, a common measure of disease activity and thus treatment efficacy, seem to be influenced by season. This could bias trials aimed at assessing the effect of drugs on disease activity and need to be considered when designing future studies.

JONATAN SALZER, M.D., is a doctoral student in the department of pharmacology and clinical neuroscience at Umeå (Sweden) University. He has no relevant disclosures.

Vitals

Pages

Recommended Reading

Biomarker Helped Predict CV Risk From NSAIDs
MDedge Family Medicine
Spleen Tyrosine Kinase Inhibitor Eased RA
MDedge Family Medicine
OA Patients at Substantial Cardiovascular Risk
MDedge Family Medicine
Advisory Panel Rejects Sodium Oxybate for Fibromyalgia
MDedge Family Medicine
Low Vitamin K Linked to Knee Osteoarthritis
MDedge Family Medicine
Panel Proposes MRI Role in Knee OA Diagnosis
MDedge Family Medicine
Statin Use Linked to 57% Reduction in Knee OA Incidence
MDedge Family Medicine
Six-Year Zoledronic Acid Regimen Safe, Effective
MDedge Family Medicine
Study: Use of Statins May Limit Effect of Rituximab in RA
MDedge Family Medicine
BMD at Bisphosphonate's End Predicts Fractures
MDedge Family Medicine